Home
About
- Our team
- Info
- David Wallace Bio
  David Wallace
  
  Founder & CEO of MPN Cancer Connection and PV Reporter | Patient Advocate
  When David was diagnosed with PV in 2009, at the age of 47, he soon learned there was limited and often conflicting information available on Myeloproliferative Neoplasms (MPNs). He also realized early on in his diagnosis, the importance of advocating for himself to best manage his polycythemia vera (PV). David was grateful for the early support and guidance of fellow MPN patients on his journey and wanted a way to give back to the MPN community. With a professional background in business administration and sociology, David has a passion for finding solutions and helping others. In 2013, David used his skill set to create PV Reporter, a comprehensive patient-focused website for MPNs. David refers to his site as a hub for patients to begin to research their cancer. Whether a patient, caregiver or healthcare provider, PV Reporter offers visitors a wealth of educational resources, patient stories, articles, and the latest news on the treatment for MPNs, helping MPN patients and their caregivers stay informed, connected and empowered. In 2015, along with the help of others, David founded a non-profit MPN Cancer Connection (MPN-CC), a patient-led 501©3 formed to create awareness that MPN patients are “cancer patients” and should have complete access to local and national programs and benefits. David’s philosophy is to educate patients to become their own advocates so that they can make informed decisions on their treatment. David’s dedication to the MPN community is further evidenced through his work and awards:
  - Selected to endorse 2018 NCCN guidelines for MPN patients by MPN Cancer Connection
  - Selected to represent the United States as a patient advocate by MPNs Advocate Network International Conference 2016-2019
  - Recipient of MPN Hero Award 2016
  - Published in MD Anderson Cancer Center MPN Focus Newsletter Fall 2016
  - Appearance on “The Doctors” TV show in 2015 to promote MPN awareness
  - Awarded Press Credentials for American Society of Hematology Conference 2014-2019
  - Contributor to Patient Power MPN educational videos
  David lives in Charlotte, North Carolina. When he’s not working, David enjoys spending time with family, listening to live music, attending outdoor festivals, watching the Carolina Panthers, riding his motorcycle, traveling and of course having his beloved Aussiedoodle Bailey by his side.
Resources
- Partners
- Groups
MPN-CC Vision
Donate
- Corporate Sponsors
Blog
Contact

Donate

Blog

September 20, 2016

Published by mpncancer at September 20, 2016

Categories

Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera

Key points The novel IFNα-2b AOP2014 administered once every two weeks (or once a month) has low toxicity and induces high and sustained response rates in […]

August 30, 2016

Published by mpncancer at August 30, 2016

Categories

Understanding the JAK2 Mutation

THE STORY OF JAK2 Four teams race to find the mysterious cause of a group of blood cancers. Click the link below for the complete article…

August 28, 2016

Published by mpncancer at August 28, 2016

Categories

Incidence, Survival and Prevalence Statistics of Classical Myeloproliferative Neoplasm in Korea

J Korean Med Sci. 2016 Oct;31(10):1579-1585. English. Published online Jul 22, 2016. http://dx.doi.org/10.3346/jkms.2016.31.10.1579 © 2016 The Korean Academy of Medical Sciences. Incidence, Survival and Prevalence Statistics of […]

August 17, 2016

CRISPR being studied for cancer treatment

Published by mpncancer at August 17, 2016

Categories

Scientists are going to use CRISPR on humans next month to try and cure cancer

Scientists in China are about to become the first to use the game-changing gene-editing technology Crispr-Cas9 on humans. Last week, Nature reported that researchers at Sichuan […]

August 16, 2016

Published by mpncancer at August 16, 2016

Categories

Bone Marrow transplant without using chemo – Scientists create a safer way

Scientists have devised a way to destroy blood stem cells in mice without using chemotherapy or radiotherapy, both of which have toxic side effects. Blood stem […]

August 15, 2016

Published by mpncancer at August 15, 2016

Categories

Blog

Physical Activity a Nonpharmacological Approach in Symptom Management in Myeloproliferative Neoplasms

Conclusions: MPN patients are understudied and there are currently no studies that have explored the effects of physical activity on sympton burden and QoL in these […]